Lv1
10 积分 2026-03-04 加入
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
3小时前
待确认
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
23天前
已完结
First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa
1个月前
已完结
In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020)
1个月前
已完结
In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China
1个月前
已完结
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa
1个月前
已完结
Emergence of cefiderocol resistance mediated by blaAFM-1 overexpression and FptA mutations in clinical carbapenem-resistant Pseudomonas aeruginosa isolates
1个月前
已关闭
Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate
2个月前
已完结
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
3个月前
已完结
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
5个月前
已完结
皖公网安备34019202002308
